Publications by authors named "Mohammed Howladar"

Claim this Profile
T
Targeting the MDM2-p53 Interaction with Siremadlin: A Promising Therapeutic Strategy for Treating Wild-Type Chronic Lymphocytic Leukemia.
Erhan Aptullahoglu, Mohammed Howladar, Jonathan P Wallis, Helen Marr, Scott Marshall

Cancers (Basel)ยท January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis